Imeik Technology Development Co Cash Flow Conversion Efficiency

Latest as of December 2025: 0.032x

Imeik Technology Development Co cash flow conversion efficiency. Based on the latest financial reports, Imeik Technology Development Co (300896) has a cash flow conversion efficiency ratio of 0.032x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥257.61 Million ≈ $37.70 Million USD) by net assets (CN¥8.16 Billion ≈ $1.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Imeik Technology Development Co (2014–2025)

Cash flow conversion efficiency of Imeik Technology Development Co from 2014 to 2025. This chart illustrates how Imeik Technology Development Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300896 live share price for real-time trading data and today's change.

Imeik Technology Development Co Cash Flow Conversion Ratio Explained

Imeik Technology Development Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Imeik Technology Development Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imeik Technology Development Co ranked by their cash flow conversion efficiency. Also see market cap of Imeik Technology Development Co for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Kaori Heat Treatment Co Ltd
TW:8996
0.163x
Aris Mining Corporation
NYSE MKT:ARMN
0.070x
Comstock Resources Inc
NYSE:CRK
0.054x
Lien Viet Post Joint Stock Commercial Bank
VN:LPB
0.284x
Grinm Advanced Materials Co Ltd
SHG:600206
-0.092x
MAZDA MOTOR UNSP.ADR/2
F:MZA0
N/A
Neway Valve suzhou Co Ltd
SHG:603699
0.151x
Cathay Biotech Inc
SHG:688065
-0.003x

Annual Cash Flow Conversion Efficiency for Imeik Technology Development Co (2014–2025)

The table below shows the annual cash flow conversion efficiency of Imeik Technology Development Co from 2014 to 2025. Review cash generation quality of Imeik Technology Development Co to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥8.16 Billion
≈ $1.19 Billion
CN¥1.39 Billion
≈ $202.93 Million
0.170x -29.93%
2024-12-31 CN¥7.95 Billion
≈ $1.16 Billion
CN¥1.93 Billion
≈ $282.01 Million
0.242x -19.55%
2023-12-31 CN¥6.49 Billion
≈ $948.97 Million
CN¥1.95 Billion
≈ $285.94 Million
0.301x +50.06%
2022-12-31 CN¥5.95 Billion
≈ $870.05 Million
CN¥1.19 Billion
≈ $174.71 Million
0.201x +7.13%
2021-12-31 CN¥5.03 Billion
≈ $736.01 Million
CN¥942.78 Million
≈ $137.96 Million
0.187x +99.53%
2020-12-31 CN¥4.53 Billion
≈ $663.06 Million
CN¥425.68 Million
≈ $62.29 Million
0.094x -79.90%
2019-12-31 CN¥662.70 Million
≈ $96.97 Million
CN¥309.72 Million
≈ $45.32 Million
0.467x +39.60%
2018-12-31 CN¥404.74 Million
≈ $59.23 Million
CN¥135.50 Million
≈ $19.83 Million
0.335x +30.60%
2017-12-31 CN¥328.31 Million
≈ $48.04 Million
CN¥84.16 Million
≈ $12.32 Million
0.256x +23.74%
2016-12-31 CN¥265.49 Million
≈ $38.85 Million
CN¥55.00 Million
≈ $8.05 Million
0.207x -35.02%
2015-12-31 CN¥151.66 Million
≈ $22.19 Million
CN¥48.35 Million
≈ $7.07 Million
0.319x +0.43%
2014-12-31 CN¥88.06 Million
≈ $12.89 Million
CN¥27.95 Million
≈ $4.09 Million
0.317x --

About Imeik Technology Development Co

SHE:300896 China Medical Instruments & Supplies
Market Cap
$3.93 Billion
CN¥26.86 Billion CNY
Market Cap Rank
#4033 Global
#543 in China
Share Price
CN¥88.78
Change (1 day)
+3.40%
52-Week Range
CN¥85.50 - CN¥160.97
All Time High
CN¥570.69
About

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate compos… Read more